Regencell Bioscience Files F-3ASR Shelf Registration

TL;DR

Regencell Bioscience just filed an F-3ASR, meaning they can now sell stock whenever they want. Big news for potential investors.

AI Summary

Regencell Bioscience Holdings Ltd. filed an F-3ASR registration statement on March 30, 2026, for an automatic shelf offering. This filing allows the company to register a continuous offering of securities, though no specific dollar amount or number of shares were detailed in this initial filing. The company's business address is in Hong Kong.

Why It Matters

This filing indicates Regencell Bioscience is preparing to potentially raise capital through future stock offerings, which could impact its financial structure and growth strategies.

Risk Assessment

Risk Level: medium — F-3ASR filings are routine for well-known seasoned issuers and don't inherently signal distress, but they do indicate a potential for future dilution or capital raising activities.

Key Players & Entities

• Regencell Bioscience Holdings Ltd (company) — Filer of the registration statement
• 0001829667 (company) — CIK number for Regencell Bioscience Holdings Ltd
• March 30, 2026 (date) — Filing date of the F-3ASR
• OgiER (Cayman) LLP (company) — Provider of legal opinion on securities validity
• Marcum Asia CPAs LLP (company) — Independent registered public accounting firm

FAQ

Key Financial Figures

• $0.00001 — s offer and sell our ordinary shares of $0.00001 par value each. In addition, from time
• $25.67 — rdinary shares on the Nasdaq Market was $25.67 per ordinary share. Investing in our s
• $ — uo;CEO”) and director; “US$,” “$” or “US do
• $1,000,000 — horized share capital of the Company is $1,000,000 divided into 100,000,000,000 Ordinary S

Filing Documents

• ea0279048-f3asr_regencell.htm (F-3ASR) — 268KB
• ea027904801ex5-1.htm (EX-5.1) — 72KB
• ea027904801ex23-1.htm (EX-23.1) — 2KB
• ea027904801ex-fee.htm (EX-FILING FEES) — 13KB
• ea027904801-img1.jpg (GRAPHIC) — 18KB
• ea027904801_ex5-1img1.jpg (GRAPHIC) — 3KB
• ea027904801_ex23-1img1.jpg (GRAPHIC) — 55KB
• 0001213900-26-035884.txt ( ) — 575KB
• ea027904801ex-fee_htm.xml (XML) — 5KB

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS iii OUR COMPANY 1

USE OF PROCEEDS

USE OF PROCEEDS 3 DESCRIPTION OF SHARE CAPITAL 4 ENFORCEABILITY OF CIVIL LIABILITIES 21 TAXATION 22 SELLING SHAREHOLDERS 23 PLAN OF DISTRIBUTION 24 LEGAL MATTERS 26 EXPERTS 27 WHERE YOU CAN FIND MORE INFORMATION ABOUT US 28 INCORPORATION OF DOCUMENTS BY REFERENCE 29 i ABOUT THIS PROSPECTUS We are a “well-known seasoned issuer” as defined in Rule 405 under the Securities Act of 1933, as amended, or the Securities Act. This prospectus is part of an automatic shelf registration statement that we filed with the Securities and Exchange Commission, or the SEC. By using an automatic shelf registration in one or more offerings. We may also add, update or change information contained in this prospectus by means of a prospectus supplement or by incorporating by reference information that we file or furnish to the SEC. As allowed by the SEC rules, this prospectus and any accompanying prospectus supplement do not contain all of the information included in the registration statement. For further information, we refer you to the registration statement, including its exhibits. Statements contained in this prospectus or any prospectus supplement about the provisions or contents of any agreement or other document are not necessarily complete. If the SEC’s rules and regulations require that an agreement or document be filed as an exhibit to the registration statement, please see that agreement or document for a complete description of these matters. You should carefully read this document and any applicable prospectus supplement. You should also read the documents we have referred you to under “Where You Can Find More Information About Us” and “Incorporation of Documents by Reference” below for information on our company, the risks we face and our financial statements. The

View Full Filing

View this F-3ASR filing on SEC EDGAR